Literature DB >> 28861306

The predictive value of platelet to lymphocyte and neutrophil to lymphocyte ratio in determining urethral stricture after transurethral resection of prostate.

Murat Gül1, Emre Altıntaş2, Mehmet Kaynar2, Muhammet Serdar Buğday1, Serdar Göktaş2.   

Abstract

OBJECTIVE: The pathology of urethral stricture disease is still unclear however progressive inflammation may contribute to the development of urethral stricture. The platelet-to- lymphocyte ratio (PLR) is a new and simple marker that indicates inflammation. In this study we aimed to investigate the predictive value of neutrophil to lymphocyte ratio (NLR) and PLR in patients with urethral stricture who underwent transurethral resection of prostate (TURP).
MATERIAL AND METHODS: A total of 208 patients who underwent bipolar-TURP were included in this study. Patients who had previously undergone surgery due to any urethral pathology, posterior urethral strictures, previous or ongoing treatment for any cancer, hematologic disorders, presence of an active infection at the time of surgical intervention, and prior blood transfusion were excluded. PLR, NLR and red cell distribution width (RDW) levels were measured. In order to investigate the predictive values of NLR and PLR variables, binary logistic regression analysis was performed.
RESULTS: No statistically significant differences were observed between the groups in terms of age, NLR, RDW, prostate size and operative times. Statistically significant differences were presented only in the median PLR- values. For predicting urethral stricture, the optimal cut-off value was 112.5, (sensitivity: 0.84, specificity: 0.64; AUC=0.762, 95% CI 0.684-0.84).
CONCLUSION: In this study we showed that PLR can be used to determine urethral stricture as a cost-effective, common, and simple biomarker in patients after TURP.

Entities:  

Keywords:  Inflammation; neutrophil to lymphocyte ratio; platelet to lymphocyte ratio; urethral stricture

Year:  2017        PMID: 28861306      PMCID: PMC5562253          DOI: 10.5152/tud.2017.14478

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  23 in total

1.  Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate.

Authors:  Alessandro Sciarra; Stefano Salciccia; Luca Albanesi; Antonio Cardi; Giuseppe D'Eramo; Franco Di Silverio
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

2.  Changes in uroflowmetry maximum flow rates after urethral reconstructive surgery as a means to predict for stricture recurrence.

Authors:  Bradley A Erickson; Benjamin N Breyer; Jack W McAninch
Journal:  J Urol       Date:  2011-09-23       Impact factor: 7.450

3.  Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression.

Authors:  A I El-Sakka; H M Hassoba; R J Pillarisetty; R Dahiya; T F Lue
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

4.  Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio.

Authors:  Mehmet Kaynar; Mehmet Erol Yildirim; Murat Gul; Ozcan Kilic; Kadir Ceylan; Serdar Goktas
Journal:  Cancer Biomark       Date:  2015       Impact factor: 4.388

5.  Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.

Authors:  R Zahorec
Journal:  Bratisl Lek Listy       Date:  2001       Impact factor: 1.278

6.  Triamcinolone injection following internal urethrotomy for treatment of urethral stricture.

Authors:  Kamyar Tavakkoli Tabassi; Aliasghar Yarmohamadi; Shabnam Mohammadi
Journal:  Urol J       Date:  2011       Impact factor: 1.510

7.  Collagenase Clostridium histolyticum (Xiaflex) for the Treatment of Urethral Stricture Disease in a Rat Model of Urethral Fibrosis.

Authors:  Premsant Sangkum; Faysal A Yafi; Hogyoung Kim; Mostafa Bouljihad; Manish Ranjan; Amrita Datta; Sree Harsha Mandava; Suresh C Sikka; Asim B Abdel-Mageed; Krishnarao Moparty; Wayne J G Hellstrom
Journal:  Urology       Date:  2015-06-27       Impact factor: 2.649

8.  Transforming Growth Factor-β1 Induced Urethral Fibrosis in a Rat Model.

Authors:  Premsant Sangkum; Ahmet Gokce; Ronny B W Tan; Mostafa Bouljihad; Hogyoung Kim; Sree Harsha Mandava; Sarmad N Saleem; George F Lasker; Faysal A Yafi; Zakaria Y Abd Elmageed; Krishnarao Moparty; Suresh C Sikka; Asim B Abdel-Mageed; Wayne J G Hellstrom
Journal:  J Urol       Date:  2015-02-10       Impact factor: 7.450

9.  Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients.

Authors:  Kultigin Turkmen; Fatih Mehmet Erdur; Fatih Ozcicek; Adalet Ozcicek; Emin Murat Akbas; Aysu Ozbicer; Levent Demirtas; Suleyman Turk; H Zeki Tonbul
Journal:  Hemodial Int       Date:  2013-03-24       Impact factor: 1.812

Review 10.  Efficacy and safety of local steroids for urethra strictures: a systematic review and meta-analysis.

Authors:  Kaile Zhang; Er Qi; Yumeng Zhang; Yinglong Sa; Qiang Fu
Journal:  J Endourol       Date:  2014-06-03       Impact factor: 2.942

View more
  2 in total

1.  The effect of platelet-rich plasma injection on post-internal urethrotomy stricture recurrence.

Authors:  Murat Gul; Nurhan Akaras
Journal:  World J Urol       Date:  2019-01-02       Impact factor: 4.226

2.  The contribution of the immune system to genitourinary fibrosis.

Authors:  Karen M Doersch; Daniel Barnett; Abbie Chase; Daniel Johnston; J Scott Gabrielsen
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.